Doctor of Optometry Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Scott Schachter

Optometrist Pismo Beach, CA Doctor of Optometry

NPI 1447230602 CMS profile 574709

300 James Way, Suite 210, Pismo Beach, CA 93449

Open in the dashboard

General payments

$311,871

496 records reported · program years 2019–2023

Research payments

$42,922

Paid to them · 3 records reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Scott Schachter of Pismo Beach, CA is reported in the CMS Open Payments database as having received $311,871 across 496 general payments and $42,922 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Optometrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2023 Research $20,471 1
2022 General $4,250 1
2021 General $34,827 52
2021 Research $5,250 1
2020 General $69,216 84
2020 Research $17,201 1
2019 General $203,578 359

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Scott Schachter
  • Optometrist median
  • Middle half of Optometrist
  • National median

In program year 2025, general payments to Scott Schachter were reported at $0. Among 35,373 Optometrist profiles paid that year, the median was $204 and the middle half received between $87 and $464.

Show as a table
Year Scott Schachter Optometrist median Middle half National median
2019 $203,578 $159 $67–$371 $163
2020 $69,216 $72 $29–$165 $114
2021 $34,827 $125 $46–$292 $132
2022 $4,250 $162 $66–$374 $149
2023 $0 $177 $72–$406 $160
2024 $0 $188 $77–$427 $164
2025 $0 $204 $87–$464 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. Shire North American Group Inc $73,126 196 payments
  2. Novartis Pharmaceuticals Corporation $46,988 68 payments
  3. Sun Pharmaceutical Industries Inc. $46,712 57 payments
  4. Allergan Inc. $34,917 47 payments
  5. Sight Sciences, Inc. $28,594 36 payments
  6. Lumenis, Inc $22,071 2 payments
  7. MacuLogix, Inc. $19,056 18 payments
  8. Kala Pharmaceuticals, Inc. $18,073 26 payments
  9. Dompe US, Inc. $11,347 17 payments
  10. Alcon Vision LLC $8,543 16 payments
  11. Other $2,444 13 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Consulting Fee $104,102 65 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $103,845 41 payments
  3. Honoraria $47,650 19 payments
  4. Travel and Lodging $41,862 158 payments
  5. Food and Beverage $13,172 208 payments
  6. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $1,200 1 payment
  7. Education $21 3 payments
  8. Gift $19 1 payment
Products named General payments · program years 2019–2023
  1. XIIDRA Opthalmics $63,462 176 payments
  2. Cequa $46,712 57 payments
  3. TearCare $28,094 35 payments
  4. XIIDRA Ophthalmology $25,224 29 payments
  5. AdaptDx $19,056 18 payments
  6. EYSUVIS $16,812 21 payments
  7. XIIDRA Ophthalmology $16,220 31 payments
  8. RESTASIS MULTIDOSE $10,746 11 payments
  9. OXERVATE $8,416 9 payments
  10. RESTASIS $7,321 13 payments
  11. Other $16,461 54 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2023
  1. Dompe US, Inc. $37,672 2 payments
  2. Novartis Pharmaceuticals Corporation $5,250 1 payment

Records

499 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Optometrist in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record